696
Views
54
CrossRef citations to date
0
Altmetric
Review

Management of the behavioral and psychological symptoms of dementia

&
Pages 611-621 | Published online: 15 Jan 2008

References

  • AupperlePKoumarasBChenM2004Long term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer’s Disease: Results of a 52-week open-label studyCurr Med Res Opin2016051215462693
  • BallardCWaiteJBirksJ2006Atypical antipsychotics for aggression and psychosis in Alzheimer’s DiseaseCochrane Database of Systematic Reviews1CD003476
  • BallardCO’BrienJReicheltK2002Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with “MelissaJ Clin Psychiatry63553812143909
  • BallardCGraceJMcKeithI1998Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer’s diseaseLancet351103239546516
  • BenedettiRCavallaroRSmeraldiE1999Olanzapine-induced neutropenia after clozapine-induced neutropeniaLancet3545667
  • CarsonSMcDonaghMPetersonK2006A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementiaJ Amer Geri Soc5435461
  • CooperJ2003Buspirone for anxiety and agitation in dementiaJ Psych Neurosci28496
  • DanielD2000Antipsychotic treatment of psychosis and agitation in the elderlyJ Clin Psych61Suppl 144952
  • De DeynPKatzIBrodatyH2005Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidoneClin Neurol and Neurosurg107497508
  • De DeynPWirshingW2001Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementiaJ Clin Psych621922
  • DeVaneCMintzerJ2003Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: An updatePsychopharm Bulletin3711632
  • DoodyRStevensJBeckC2001Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology5611546611342679
  • DouzjianMWilsonCShultzM1998A program to use pain control medication to reduce psychotropic drug use in residents with difficult behaviorAnnals of Long Term Care61749
  • EichelmanB1987Neurochemical basis of aggressive behaviorPsychiatric Ann173714
  • FeldmanHGauthierSHeckerJ2001A 24-week randomized, double-blind study of Donepezil in moderate to severe Alzheimer’s DiseaseNeurology5394655
  • FinkelSMintzerJDyskenM2004A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer’s Disease in outpatients treated with DonepezilInt J Geriatr Psych19918
  • FinkelSCostaESilvaJ1996Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatmentInt Psychogeriatr8Suppl 3S497500
  • FinkelSLyonsJAndersonR1995A randomized, placebo-controlled trial of thiothixene in agitated, demented nursing home patientsIntl Jnl Geri Psych1012936
  • GauthierS2005Drugs for Alzheimer’s Disease and related dementiasBMJ330857815831849
  • Gonzalez-SalvadorTLyketsosCBakerA2000Quality of life in dementia patients in long-term careInt J Geriatr Psych151819
  • HawkinsJTinklenbergJSheikhJ2000A retrospective chart review of Gabapentin for the treatment of aggressive and agitated behavior in patients with dementiasAm J Geriatr Psychiatry8221510910420
  • JesteDRockwellEHarrisM1999Conventional versus newer antipsychotics in elderly patientsAm J Geriatr Psych7706
  • JonesPBarnesTDaviesL2006Randomized controlled trial of the effect on quality of life of second vs first generation antipsychotic drugs in schizophreniaArch Gen Psychiatry6310798717015810
  • KatzIJesteDMintzerJ1999Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trialJ Clin Psych6010715
  • KindermannSDolderCBaileyA2002Pharmacological treatment of psychosis and agitation in elderly patients with dementiaDrugs Aging192577612038878
  • KozmanMWattisJCurranS2006Pharmacological management of behavioral and psychological disturbance in dementiaHum Psychopharmacol Clin Exp21112
  • LanctotKHerrmannN2000Donepezil for behavioral disorders associated with Lewy bodies: a case seriesInt J Geriatr Psych1533845
  • LaneP2003A pain assessment tool for people with advanced Alzheimer’s and other progressive dementiasHome Healthcare Nurse2132712544460
  • LawlorB2004Behavioral and psychological symptoms in dementia: the role of atypical antipsychoticsJ Clin Psychiatry65Suppl 1151015264965
  • LawlorBRadcliffeJMolchanS1994A pilot placebo controlled study of trazodone and buspirone in Alzheimer’s DiseaseInt J Geriatr Psych9559
  • LeePGillSFreedmanM2004Atypical antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia: systematic reviewBMJ3297515194601
  • LovellBAncoli-IsraelSGevirtzR1995Effect of bright light treatment on agitated behavior in institutionalized elderly subjectsPsychiatry Res577127568561
  • LyketsosCDelCampoLSteinbergM2003Treating depression in Alzheimer Disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADSArch Gen Psych6073746
  • LyketsosCLopezOJonesB2002Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the Cardiovascular Health StudyJAMA28814758312243634
  • LyketsosCSteeleCBakerL1997Major and minor depression in Alzheimer’s Disease: Prevalence and impactJ Neuropsychiatry Clin Neurosci9556619447496
  • MalettaG1990Pharmacologic treatment and management of the aggressive demented patientPsychiatric Ann2044655
  • MellowASolano-LopezCDavisS1993Sodium valproate in the treatment of behavioral disturbance in dementiaJ Geriatr Psych Neurol62059
  • MilesSIrvineP1992Deaths caused by physical restraintsGerontologist3276261478494
  • NythAGottfriesC1990The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: A Nordic multicenter studyBr J Psych57894901
  • O’BrienJCaroJ2001Alzheimer’s Disease and other dementia in nursing homes: levels of management and costInt Psychogeriatr133475811768381
  • PalmerCAdamsSBourgeoisM1999Reduction in caregiver-identified problem behaviors in patients with Alzheimer Disease post-hearing aid fittingJ Speech Lang Hear Res423122810229449
  • PaulsenJSalmonDThalL2000Incidence of and risk factors for hallucinations and delusions in patients with probable ADNeurology5419657110822438
  • PautexSMichonAGuediraM2006Pain in severe dementia: self-assessment of observational scales?JAGS5410405
  • PolluckBMulsantBRosenJ2002Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patientsAm J Psychiatry159460511870012
  • PolluckBMuylsantBSweetR1997An open pilot study of citalopram for behavioral disturbances of dementiaAm J Geriatr Psych5708
  • RoslerMRetzWRetz-JungingerP1999Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioral symptoms in Alzheimer’s DiseaseBehav Neurol112111611568422
  • RovnerBGermanPBroadheadJ1990The prevalence and management of dementia and other psychiatric disorders in nursing homesInt Psychogeriatr213242101294
  • SchneiderLDagermanKInselP2005Risk of death with atypical antipsychotic drug treatment for dementiaJAMA29419344316234500
  • SchneiderLDagermanKInselP2006Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trialsAm J Geriatr Psych14191210
  • SchneiderLTariotPDagermanK2006Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s DiseaseNEJM35515253817035647
  • ShankleWNielsonKCotmanC1995Low dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly dementedAlzheimer Dis Assoc Disord923378749613
  • SinkKHoldenKYaffeK2005Pharmacological treatment of neuropsychiatric symptoms of dementiaJAMA29359660815687315
  • SloanePHoefferBMitchellC2004Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: a randomized, controlled trialJ Amer Geri Soc521795804
  • SmallwoodJBrownRCoulterF2001Aromatherapy and behavior disturbances in dementia: A randomized controlled trialInt J Geriatr Psych16101013
  • SteeleCRovnerBChaseB1990Psychiatric symptoms and nursing home placement of patients with Alzheimer’s DiseaseAmer Jnl Psych147104951
  • SternYMayeuxRSanoM1987Predictors of disease course in patients with probable Alzheimer’s DiseaseNeurology371649533658173
  • StoppeGBrandtCStaedtJ1999Behavioral problems associated with dementia. The role of newer antipsychoticsDrugs and Aging14415410069407
  • StreimJ1995OBRA regulations and psychiatric care in the nursing homePsychiatric Ann2541318
  • SultzerDGrayKGunayI1997A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementiaAm J Geriatr Psych5609
  • TariotPErbRLeiboviciA1994Carbamazepine treatment of agitation in nursing home patients with dementia: A preliminary studyJAGS4211606
  • TariotPFarlowMGrossbergG2004Memantine treatment in patients with moderate to severe Alzheimer’s Disease already receiving Donepezil: A randomized controlled trialJAMA2913172414734594
  • TariotPProfennoLIsmailM2004Efficacy of atypical antipsychotics in elderly patients with dementiaJ Clin Psychiatry65Suppl 11111515264966
  • TeriLGibbonsLMcCurryS2003Exercise plus behavioral management in patients with Alzheimer DiseaseJAMA29020152214559955
  • WangPSchneeweissSAvornJ2005Risk of death in elderly users of conventional vs. atypical antipsychotic medicationsNEJM35323354116319382
  • WeinerMKossEWildK1996Measure of psychiatric symptoms in Alzheimer patients: A reviewAlzheimer Dis Assoc Disord1020308919493
  • ZaudigM2000A risk-benefit assessment of risperidone for the treatment of behavioral and psychological symptoms in dementiaDrug Safety231839511005702